Actimus Biosciences Private Limited

Actimus Biosciences Private Limited - life sciences in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U74140AP2004PTC042512 Incorporated 28 January 2004 ROC Vijayawada HQ Visakhapatnam, Andhra Pradesh, India
Active Private Limited Company life sciences MSME · Medium
Data last updated
Revenue · FY 2025
₹53.57 Cr
▲ 10% YoY
Net profit · FY 2025
₹6.06 Cr
Net margin 11.3%
EBITDA · FY 2025
₹10.58 Cr
EBITDA margin 19.8%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Open charges
₹28.38 Cr
Satisfied ₹5.35 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
273
Provident fund records

About Actimus Biosciences Private Limited

Data last updated:

Actimus Biosciences Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India, a subsidiary of Actimus Inc. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 28 January 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U74140AP2004PTC042512. Its GSTIN is 37AACCT1298A2ZH (Andhra Pradesh). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.5 Cr. It was formerly known as Tavisa Biosciences Private Limited. It is led by directors including Ajjagottu Ramanathareddy (Managing Director) and Devadi Srinivasa Rao.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4th Floor Varun Towers 7 – 8 – 1/3 Kasturigba Marg Siripuram, Visakhapatnam, Andhra Pradesh, India – 530003.

As per the financials filed for FY 2025, the company reported a revenue of ₹53.57 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹6.06 Cr (net margin 11.3%) and EBITDA of ₹10.58 Cr (EBITDA margin 19.8%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 18% over five years.

The company has about 273 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Actimus Bio. As per MCA filings, the company has open charges of ₹28.38 Cr and satisfied charges of ₹5.35 Cr on record. Court records list 5 cases involving the company, including 5 filed against it. The company has 10 deals on record (5 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹3.06 Cr; the latest was in March 2023.

Actimus Biosciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0015791). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website actimusbio.com.

Company details

CIN U74140AP2004PTC042512
Registration Number 042512
Incorporation Date 28 January 2004
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Actimus Inc
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-AP-10-0015791

Recognitions & Rankings of Actimus Biosciences

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-AP-10-0015791

Contact details

Actimus Biosciences Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its website is actimusbio.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    4th Floor Varun Towers 7 – 8 – 1/3 Kasturigba Marg Siripuram, Visakhapatnam, Andhra Pradesh, India – 530003
  • Industry
    Life Sciences, Biotechnology

To see the full contact details of Actimus Biosciences Private Limited, buy the company report.

Comprehensive company report
Actimus Biosciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Actimus Biosciences operates one associated brand: Actimus Bio. Each brand links to its own profile.

BrandDescriptionWebsite
Offers bioanalytical, clinical trials, and analytical services for drug development globally.actimusbio.com

Business activity

The main business activity of Actimus Biosciences is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of Actimus Biosciences Private Limited, buy the company report.

Financials of Actimus Biosciences Private Limited

FY 2025 filings available

Actimus Biosciences Private Limited reported revenue of ₹53.57 Cr (up 10% YoY) for FY 2025.

Revenue · FY 2025
₹53.57 Cr ▲ 10%
Net profit · FY 2025
₹6.06 Cr margin 11.3%
EBITDA · FY 2025
₹10.58 Cr margin 19.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 21%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 45%
5 years · compounded
▲ 21%

Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 10% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.58 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.06 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin19.8%
Net Profit Margin11.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Actimus Biosciences Private Limited, buy the company report.

Board of directors of Actimus Biosciences Private Limited

Actimus Biosciences has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Devadi Srinivasa RaoDirector26 Mar 201313 Years 6 MonthsCurrent
Ajjagottu RamanathareddyManaging Director28 Jan 200422 Years 8 MonthsCurrent
Devadi Shiva KumarDirector26 Jul 20251 Years 2 MonthsCurrent

Auditor

Actimus Biosciences Private Limited is audited by M K M and CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
M K M and COFY 2023221554

Shareholding

The shareholding of Actimus Biosciences Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Actimus Biosciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹28.38 Cr
Satisfied charges
₹5.35 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹28.38 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 May 2025101106404Hdfc Bank Limited₹28.38 CrOpen
01 Oct 2015100029051Canara Bank₹3.5 CrSatisfied
16 Apr 201110288052State Bank of India₹85 LakhSatisfied
18 Nov 200810132732State Bank of India₹1 CrSatisfied

To see the full charge records of Actimus Biosciences Private Limited, buy the company report.

Total charge records: 4 View all charges

Deals & funding

Actimus Biosciences Private Limited has 10 deals on record (5 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹3.06 Cr; the latest was in March 2023.

Total deals
10
Secondary share transfers
5
Funding rounds
4
Rights issue
1
Disclosed funding
₹3.06 Cr

Deals on record (5 of 10)

WhenDealAmountParties
Mar 2023Secondary share transferUndisclosedBuyer: 2 individuals
Seller: Actimus Inc
Jul 2018Rights issue₹2.21 CrInvestors: Actimus Inc
Mar 2017Funding round₹47.1 LakhInvestors: Actimus Inc
Mar 2013Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2008Secondary share transferUndisclosedBuyer: Actimus Inc
Seller: 2 individuals

To see the full deal history of Actimus Biosciences Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Actimus Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Actimus Biosciences Private Limited has a workforce of 273 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.

Employee count
273
Active EPFO establishments
1
Employee growth
20.8%

GST

Actimus Biosciences has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
37AACCT1298A2ZHAndhra PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Actimus Biosciences Private Limited, buy the company report.

Recent activity

Actimus Biosciences Private Limited has 11 board changes on record since 2004: 4 appointments and 7 cessations. The latest: Devadi Shiva Kumar was appointed as Director on 26 Jul 2025.

AGM
Actimus Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Devadi Shiva Kumar was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 28.38 Cr with Charge ID 101106404 was registered on 30 May 2025.
Filing
Actimus Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Charges
A charge registered on 01 Oct 2015 via Charge ID 100029051 with Canara Bank was fully satisfied on 03 Jul 2023.
Appointed
Devadi Pavan Kumar was appointed as Additional Director.
Ceased
Devadi Srinivasa Rao ceased to be Director.
Ceased
Manoj Lanka ceased to be Additional Director.
Charges
A charge registered on 16 Apr 2011 via Charge ID 10288052 with State Bank Of India was fully satisfied on 18 Jan 2017.
Charges
A charge registered on 18 Nov 2008 via Charge ID 10132732 with State Bank Of India was fully satisfied on 18 Jan 2017.
Charges
A charge with Canara Bank amounted to Rs. 3.50 Cr with Charge ID 100029051 was registered on 01 Oct 2015.
Ceased
Srinivas Reddy Maram ceased to be Director.

9 earlier events are in the company report.

Frequently asked questions

Actimus Biosciences is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 28 January 2004 (22+ years old) and is registered under CIN U74140AP2004PTC042512.

Actimus Biosciences has 3 current directors:

The latest financial statements of Actimus Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Actimus Biosciences is 37AACCT1298A2ZH, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Actimus Biosciences is U74140AP2004PTC042512. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Actimus Biosciences has 5 court cases on record: 5 filed against it.

Actimus Biosciences was incorporated on 28 January 2004, making it 22+ years old. It is registered with the Registrar of Companies, Vijayawada.

Actimus Biosciences has 10 deals on record (5 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹3.06 Cr; the latest was in March 2023.

Devadi Shiva Kumar was appointed as Director on 26 Jul 2025. Devadi Pavan Kumar was appointed as Additional Director on 16 Feb 2022. Devadi Srinivasa Rao ceased to be Director on 08 Feb 2022. Actimus Biosciences has 11 board changes on record in total.

Yes, Actimus Biosciences is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-10-0015791).